Drug
Abemaciclib
Abemaciclib: highest development phase Phase 2, developed by Mirati Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Mirati Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Abemaciclib NCT03994796 | Phase 2 | CDK Gene Mutation |
Latest
No recent events.
Follow Abemaciclib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.